Gender differences during mechanical circulatory support

ASAIO Journal

Volumn 58, Issue 4, 2012, Pages 320-325

  Potapov, Evgenij ^a   Schweiger, Martin ^a,b   Lehmkuhl, Elke ^a   Vierecke, Juliane ^a   Stepanenko, Alexander ^a   Weng, Guyo ^a   Pasic, Miralem ^a   Huebler, Michael ^a   Regitz Zagrosek, Vera ^a   Hetzer, Roland ^a   Krabatsch, Thomas ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT POPULATIONS; AGE GROUPS; CARDIAC SURGERY; DILATED CARDIOMYOPATHY; GENDER DIFFERENCES; GENDER DISTRIBUTION; HEART FAILURE; MEAN AGES; MECHANICAL CIRCULATORY SUPPORT; MEDIAN WEIGHT; PATIENT POPULATION; SEX-RELATED DIFFERENCES; SIGNIFICANT IMPACTS; VENTRICULAR ASSIST DEVICE;

CARDIOLOGY; CARDIOVASCULAR SURGERY; DIAGNOSIS; LEFT VENTRICULAR ASSIST DEVICES; POPULATION STATISTICS; SOCIAL SCIENCES;

POPULATION DISTRIBUTION;

ADOLESCENT; ADULT; AGED; ARTICLE; ASSISTED CIRCULATION; CARDIOLOGY; CARDIOMYOPATHY; CHILD; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEART SURGERY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PROGNOSIS; SEX DIFFERENCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASSISTED CIRCULATION; CARDIAC SURGICAL PROCEDURES; CARDIOLOGY; CARDIOMYOPATHIES; CHILD; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SEX FACTORS; TREATMENT OUTCOME;

EID: 84863533709     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e318251cdf9     Document Type: Article

References (36)

1. Levy D, Kenchaiah S, Larson MG, et al: Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347: 1397-1402, 2002. (Pubitemid 35239711)
2. Regitz-Zagrosek V, Petrov G, Lehmkuhl E, et al: Heart transplantation in women with dilated cardiomyopathy. Transplantation 89: 236-244, 2010.
3. Hetzer R, Potapov EV, Alexi-Meskishvili V, et al: Single-center experience with treatment of cardiogenic shock in children by pediatric ventricular assist devices. J Thorac Cardiovasc Surg 141: 616-23, 623.e1, 2011.
4. Regitz-Zagrosek V, Oertelt-Prigione S, Seeland U, Hetzer R: Sex and gender differences in myocardial hypertrophy and heart failure. Circ J 74: 1265-1273, 2010.
5. Taylor DO, Stehlik J, Edwards LB, et al: Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009. J Heart Lung Transplant 28: 1007-1022, 2009.
6. Regitz-Zagrosek V, Lehmkuhl E, Hocher B, et al: Gender as a risk factor in young, not in old, women undergoing coronary artery bypass grafting. J Am Coll Cardiol 44: 2413-2414, 2004. (Pubitemid 39647621)
7. Morgan JA, Weinberg AD, Hollingsworth KW, Flannery MR, Oz MC, Naka Y: Effect of gender on bridging to transplantation and posttransplantation survival in patients with left ventricular assist devices. J Thorac Cardiovasc Surg 127: 1193-1195, 2004. (Pubitemid 38451957)
8. Morabia A, Costanza MC: International variability in ages at menarche, first livebirth, and menopause. World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Am J Epidemiol 148: 1195-1205, 1998.
9. Onland-Moret NC, Peeters PH, van Gils CH, et al: Age at menarche in relation to adult height: the EPIC study. Am J Epidemiol 162: 623-632, 2005. (Pubitemid 41437361)
10. Gillum RF: Idiopathic cardiomyopathy in the United States, 1970-1982. Am Heart J 111: 752-755, 1986. (Pubitemid 16104591)
11. Codd MB, Sugrue DD, Gersh BJ, Melton LJ III: Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation 80: 564-572, 1989. (Pubitemid 19231390)
12. Lloyd-Jones D, Adams R, Carnethon M, et al: American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: 480-486, 2009.
13. Kärkkäinen S, Peuhkurinen K: Genetics of dilated cardiomyopathy. Ann Med 39: 91-107, 2007. (Pubitemid 46598173)
14. Cleland JG, Swedberg K, Follath F, et al: Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology: The EuroHeart Failure survey programme-A survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24: 442-463, 2003. (Pubitemid 36286187)
15. Lenzen MJ, Rosengren A, Scholte op Reimer WJ, et al: Management of patients with heart failure in clinical practice: differences between men and women. Heart 94: e10, 2008.
16. O'Meara E, Clayton T, McEntegart MB, et al; CHARM Investigators: Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 115: 3111-3120, 2007. (Pubitemid 46956500)
17. Iellamo F, Volterrani M, Caminiti G, et al: Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J Am Coll Cardiol 56: 1310-1316, 2010.
18. Merz CN, Olson MB, McClure C, et al: A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). Am Heart J 159: 987.e1-987.e7, 2010.
19. Shaw LJ, Bugiardini R, Merz CN: Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol 54: 1561-1575, 2009.
20. Olivetti G, Giordano G, Corradi D, et al: Gender differences and aging: effects on the human heart. J Am Coll Cardiol 26: 1068-1079, 1995.
21. Carroll JD, Carroll EP, Feldman T, et al: Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 86: 1099-1107, 1992.
22. Weinberg EO, Mirotsou M, Gannon J, Dzau VJ, Lee RT, Pratt RE: Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. Physiol Genomics 12: 113-127, 2003. (Pubitemid 37139691)
23. Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801-1811, 1999. (Pubitemid 29266405)
24. Simoncini T, Genazzani AR: Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase. J Clin Endocrinol Metab 85: 2966-2969, 2000. (Pubitemid 32269183)
25. Luchner A, Bröckel U, Muscholl M, et al: Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study. Cardiovasc Res 53: 720-727, 2002. (Pubitemid 34175264)
26. Hetzer R, Weng Y, Potapov EV, et al: First experiences with a novel magnetically suspended axial flow left ventricular assist device. Eur J Cardiothorac Surg 25: 964-970, 2004. (Pubitemid 38622336)
27. Slaughter MS, Tsui SS, El-Banayosy A, et al; IVAD Study Group: Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device. J Thorac Cardiovasc Surg 133: 1573-1580, 2007.
28. Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH: End-organ function in patients on long-term circulatory support with continuous-or pulsatile-flow assist devices. J Heart Lung Transplant 26: 815-818, 2007. (Pubitemid 47199072)
29. Kamdar F, Boyle A, Liao K, Colvin-Adams M, Joyce L, John R: Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J Heart Lung Transplant 28: 352-359, 2009.
30. Kwon DH, Halley CM, Popovic ZB, et al: Gender differences in survival in patients with severe left ventricular dysfunction despite similar extent of myocardial scar measured on cardiac magnetic resonance. Eur J Heart Fail 11: 937-944, 2009.
31. Kittleson MM, Shemin R, Patel JK, Ardehali A, Kawano M, Davis S, et al: Donor-recipient sex mismatch portends poor 10-year outcomes in a single-center experience. J Heart Lung Transplant. 30:1018-1022, 2011. Epub May 8, 2011.
32. Mehra MR, Ventura HO, Chambers RB, Ramireddy K, Smart FW, Stapleton DD: The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal. J Heart Lung Transplant 16: 743-751, 1997. (Pubitemid 27319150)
33. Baumwol J, Macdonald PS, Keogh AM, et al: Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomeV s. J Heart Lung Transplant 30: 888-895, 2011.
34. Potapov E, Meyer D, Swaminathan M, Ramsay M, El Banayosy A, Diehl C, et al: Inhaled nitric oxide after left ventricular assist device implantation: A prospective, randomized, double-blind, multicenter, placebo-controlled trial. J Heart Lung Transplant. 30:870-878, 2011. Epub Apr 29, 2011.
35. Potapov EV, Hennig F, Wagner FD, et al: Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure. Eur J Cardiothorac Surg 27: 899-905, 2005. (Pubitemid 40585688)
36. Kormos RL, Gasior TA, Kawai A, et al: Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support. J Thorac Cardiovasc Surg 111: 773-82; discussion 782, 1996.